NURECA
|
NURECA Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹-2.54 Cr | ₹-11 Cr | ₹61 Cr | ₹62 Cr | ₹8.61 Cr |
Adjustment | ₹-6.76 Cr | ₹-3.48 Cr | ₹-3.73 Cr | ₹0.11 Cr | ₹1.17 Cr |
Changes In working Capital | ₹5.34 Cr | ₹29 Cr | ₹-38 Cr | ₹-13 Cr | ₹-18 Cr |
Cash Flow after changes in Working Capital | ₹-3.96 Cr | ₹14 Cr | ₹19 Cr | ₹50 Cr | ₹-7.92 Cr |
Cash Flow from Operating Activities | ₹-2.71 Cr | ₹10 Cr | ₹1.40 Cr | ₹35 Cr | ₹-7.92 Cr |
Cash Flow from Investing Activities | ₹18 Cr | ₹-16 Cr | ₹-3.09 Cr | ₹-110 Cr | ₹-0.39 Cr |
Cash Flow from Financing Activities | ₹-1.30 Cr | ₹-1.51 Cr | ₹-7.30 Cr | ₹92 Cr | ₹8.28 Cr |
Net Cash Inflow / Outflow | ₹14 Cr | ₹-7.74 Cr | ₹-8.99 Cr | ₹17 Cr | ₹-0.04 Cr |
Opening Cash & Cash Equivalents | ₹0.50 Cr | ₹8.25 Cr | ₹17 Cr | ₹0.07 Cr | ₹0.11 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹0.00 Cr | ₹-0.01 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Closing Cash & Cash Equivalent | ₹14 Cr | ₹0.50 Cr | ₹8.25 Cr | ₹17 Cr | ₹0.07 Cr |
Compare Cashflow Statement of peers of NURECA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NURECA | ₹218.0 Cr | 3.6% | -6% | -21.6% | Stock Analytics | |
POLY MEDICURE | ₹20,934.9 Cr | -7.9% | -3.8% | 44.5% | Stock Analytics |
NURECA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NURECA | 3.6% |
-6% |
-21.6% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses